May 6, 2020
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Pharmaceuticals, Biotechnology and Life Sciences
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation markers observed with AXA1125 along with favorable tolerability, supporting…
Spruce Biosciences has announced the appointments of Samir Gharib, MBA, CPA, as Chief Financial Officer (CFO), and Dasharatha Reddy, Ph.D., as Vice President, Pharmaceutical Development and Manufacturing.
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) announced that Norma Beauchamp has resigned as a member of…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…
Founded by Versant Ventures to develop medicines that target the innate immune system WALTHAM, Mass. & MONTREAL–(BUSINESS WIRE)–Ventus Therapeutics Inc.…
– Conference Call and Webcast Today, May 6, 2020, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq:…
– Dr. Joseph Stauffer, an anesthesiologist with deep clinical and regulatory experience, fills a key position as Antibe prepares for…
Rebiotix and Ferring are the first to announce positive preliminary results on primary efficacy endpoint from ongoing pivotal Phase 3…